CompletedNCT02596347
The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)
Studying Chronic beryllium disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Jewish Health
- Principal Investigator
- Li Li, MDNational Jewish Health
- Intervention
- Blood draw(procedure)
- Enrollment
- 3 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2015 – 2019
Study locations (1)
- National Jewish Health, Denver, Colorado, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02596347 on ClinicalTrials.gov